The global protein chip market revenue was US$ 652.8 million in 2020. The global protein chip market is forecast to reach US$ 1,367.1 million by 2030, growing at a compound annual growth rate (CAGR) of 7.5% during the forecast period from 2021-2030.

A protein chip, or a protein microarray, is a miniaturized, parallel assay system that contains small amounts of purified proteins in a high-density format. Within the same experiment, they allow the determination of a wide range of analytes from small samples. Chips consist of a support surface, such as a glass slide, nitrocellulose membrane, bead, or microtiter plate on which capture proteins adhere.

Factors Influencing Market Growth

Growing demand for personalized medicine, rising R&D investments in proteomics, increasing rates of cancer incidences, and increasing use of advanced technologies in diagnostic testing is forecast to provide the primary drivers for the protein chip market in the coming years.
A lack of healthcare coverage and technical challenges associated with protein chip technology may slow down the global protein chip market's growth in developing countries.
The growing biotech and biomedicine industries will contribute to the growth of the protein chip market.
Using protein chips to screen targets automatically is a factor that may limit the growth of the protein chip market.
Impact Analysis of COVID-19

COVID-19 outbreak has had a positive impact on the global market for protein chips. Diagnostics laboratories have had a high demand for protein microarrays due to COVID-19. The University of Michigan Hospital used a digital protein microarray platform in 2020 for rapid multiplex measurement of cytokines from COVID-19 patients admitted to the ICU to develop a personalized strategy guided by cytokine assays. China produced a SARS-CoV-2 proteome microarray in April 2020 that contained 18 out of 28 predicted proteins and used the array to analyze IgG and IgM antibodies from 29 patients recovering from the disease. In the future, these responses will assist in developing effective diagnostics, therapeutics, and vaccination strategies. In turn, this fosters the growth of the protein chip industry.

Regional Insights

North America was the leading region in the protein chip market in 2020. As a result of the region having established protein chip laboratory and research facilities.

During the forecast period, Asia-Pacific will have the highest CAGR. As a result of an increase in demand for protein microarray assays and increased awareness. Protein chip assays are developing at a rapid pace, and the cost-effectiveness of the test is forecast to drive market growth in other regions.

Leading Competitors

The leading prominent companies profiled in the global protein chip market are:

Agilent Technologies, Incorporated
Arrayit Corporation
Bio-Rad Laboratories, Incorporated
Danaher Corporation
Illumina Incorporated
Merck KGGA
Perkin Elmer
Quotient limited
Raybiotech Incorporated
Thermo Fisher Scientific
Other Prominent Players
Scope of the Report

The global protein chip market segmentation focuses on Technology, Application, End-User, and Region.

Segmentation based on Technology

Analytical Microarrays
Functional Protein Microarrays
Reverse Phase Protein Microarrays
Segmentation based on Application
Diagnostics
Proteomics
Antibody Characterization
Segmentation based on End-User

Hospitals & Clinics
Diagnostic Laboratories
Academic & Research Institutes
Pharmaceutical & Biotechnological Companies
Segmentation based on Region

North America
The U.S.
Canada
Mexico
Europe
Western Europe
The UK
Germany
France
Italy
Spain
Rest of Western Europe
Eastern Europe
Poland
Russia
Rest of Eastern Europe
Asia Pacific
China
India
Japan
Australia & New Zealand
ASEAN
Rest of Asia Pacific
Middle East & Africa (MEA)
UAE
Saudi Arabia
South Africa
Rest of MEA
South America
Brazil
Argentina
Rest of South America